http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101633624-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_378c4f2cab183e7e52f2792614ca03ca
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6632ff8d26d297452d7dfe08a29ac36d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36422f30e657c368800ae82816685fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbda9f80c30d38d505b977d32c9d087f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfa6e299316ce04a38141b7982009d31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae5753eed975bd405ac5202696d33cc
publicationDate 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101633624-B
titleOfInvention Preparation method of improved di-lysine-aspirin
abstract The invention discloses a preparation method of improved di-lysine-aspirin, comprising the following steps: adding a DL-lysine aqueous solution with the mass percentage concentration being 25-30 percent to an alcobolic solution of aspirin at the temperature of 15-25 DEG C; enabling the mass ratio of DL-lysine to aspirin to be 1:(1.3-1):1.5; mixing and crystallizing for 5-15 minutes; then adding precipitation alcohol with the mass being 3-4 times of aspirin; reducing the temperature within 10 DEG C, and mixing and culturing crystal for 0.5-1.5 hours; filtering and then obtaining crystal; and washing the crystal by an amount of absolute ethyl alcohol for 1-2 times. The invention enables the acid value of a product to be reduced below 6.0 by changing the mixture ratio of reactants, enables the crystal fluidity of the product to be enhanced by changing the flow acceleration of materials and enables the appearance and free oxybenzoic acid of the product to be improved by reducing the temperature of the whole system, thereby reducing the acrimony and the sensitization of medicines and improving the quality of aspirin.
priorityDate 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448295167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23452462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449101318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557672
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID42363
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID42363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450683113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158295377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453910039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449969072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID876

Total number of triples: 39.